Peptides are short chains of amino acids, the smallest building blocks of proteins. They are not new: they occur naturally in the body and direct processes such as skin repair, cell communication and immune responses.

In premium skincare, peptides have been a gold standard for more than twenty years. They are valued for their precision: they communicate with specific cells or structures without overloading the skin. That is the difference from broad-spectrum ingredients that target everything, including what does not need
to be touched.

The most sustainable treatment for dandruff is not one that makes the scalp sterile. It is one that brings the microbiome back into balance so the skin can maintain itself.

The scalp microbiome is a delicate ecosystem. A healthy scalp has a richer, more diverse microbial community. With dandruff, diversity decreases: Malassezia
restricta dominates, while beneficial species such as Cutibacterium acnes fade into the background. The result is a dysregulated system that repeatedly falls out of balance, even after treatment.

Conventional anti-dandruff treatments reduce Malassezia, but do not always positively influence the broader microbiome composition. Once treatment stops, the imbalance returns — sometimes more quickly, because beneficial micro-organisms have also been disrupted.

hLF1-11 works with greater selectivity. By curbing Malassezia overgrowth through direct cell wall interaction and iron sequestration, while simultaneously
strengthening local immunity, it creates the conditions under which the microbiome can restore itself. The skin does not become dependent on an
external agent — it is empowered to regain its own regulatory capacity.

On a healthy scalp, Malassezia is always present. It is a lipophilic yeast, meaning it feeds on the fatty acids in sebum. In a healthy state, Malasseziaexists in balance with other micro-organisms, including Cutibacterium acnes and Staphylococcus epidermidis.

With dandruff, that balance shifts. Malassezia restricta grows excessively, while Cutibacterium acnes declines. This is not coincidental: C.acnes produces propionic acid, which helps regulate Malassezia overgrowth. When that bacterium declines, the scalp loses part of its own self-regulatory capacity.

Inovergrowth, Malassezia metabolises sebum and produces free fatty acids such as oleic acid in the process. These fatty acids irritate the skin barrier, trigger inflammatory responses and accelerate the rate at which skin cells divide. The result: the rapid flaking we see as dandruff, combined with itching
and sometimes redness.

The solution is not to eliminate Malassezia entirely. It is always present and plays a role in the ecosystem. The solution is to restore balance: curbing the
overgrowth, supporting the skin barrier and creating the conditions in which the microbiome can self-regulate again.

That is precisely what the active ingredient in Calmbay does.

hLF1-11 is the name of the peptide at the core of the Calmbay formula. The name refers to the amino acid sequence.

Lactoferrin is a protein the human body produces itself. It is present in breast milk, saliva, tears and mucous embranes, wherever the body meets the outside world and needs to defend itself. Lactoferrin has strong antimicrobial and anti-inflammatory properties, and plays an important role in innate immunity.

Researchers discovered that much of lactoferrin's potency resides in a specific fragment. This fragment was found to possess broad antifungal activity, antimicrobial properties and immunomodulatory effects.

hLF1-11 is the synthetic, stable reproduction of this fragment. That may sound technical, but the implication is simple: it is an active ingredient the body recognises as its own. Not a foreign chemical compound, but a molecule inspired by what nature has already designed.

In the Calmbay Anti-Dandruff Scalp Treatment, this peptide acts directly on the fungal cells that cause dandruff and simultaneously on the scalp's own immune system.

hLF1-11 works through multiple mechanisms simultaneously. That is what sets it apart from conventional anti-dandruff treatments, which typically operate through a single mode of action.

Direct action on the cell wall
hLF1-11 binds to the cell wall of Malassezia and disrupts its integrity. This process leads to cytolysis: the rupture and death of the fungal cell. The yeast cannot defend itself against this mechanism, because the
peptide targets fundamental structures in the cell wall.

Depriving the environment of iron
Lactoferrin-derived peptides bind iron. Malassezia requires iron for growth and virulence. By sequestering iron from the yeast's immediate environment its growth is slowed, without placing any burden on the skin itself.

Strengthening local immunity
Beyond direct antifungal action, hLF1-11 modulates the skin's immune response. It activates monocytes and macrophages — immune cells that can themselves clear fungal cells — and regulates inflammatory signals so the skin remains calmer.

Synergy with other active ingredients
Laboratory research shows that hLF1-11 works synergistically with other antifungal agents: the combined effect is greater than the sum of its parts. This makes the peptide exceptionally well-suited as a core ingredient in a multi-active formula.

Together,these mechanisms deliver something conventional products rarely offer: targeted, lasting action on the cause, not the symptom.

The scalp is not an extension of the hair: it is skin, with its own microbiome, its own barrier function and its own vulnerability to imbalance. The challenges are specific, and call for specific active ingredients.

Calmbay uses a bio-identical peptide that acts directly on the root cause of dandruff: the overgrowth of Malassezia yeast and the associated microbiome disruption.